Operating Lease, Right-of-Use Asset of Hepion Pharmaceuticals, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Hepion Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Hepion Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$118,301 -100% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $0 -$150,733 -100% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $0 -$182,019 -100% 31 Mar 2025 10-Q 19 May 2025 2025 Q1
Q3 2024 $118,301 -$124,206 -51% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $150,733 +$150,733 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $182,019 +$182,019 31 Mar 2024 10-Q 21 May 2024 2024 Q1
Q4 2023 $212,878 +$162,293 +321% 31 Dec 2023 10-K 08 Apr 2025 2024 FY
Q3 2023 $242,507 +$142,266 +142% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $0 -$168,782 -100% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $0 -$236,519 -100% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $50,585 -$253,104 -83% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $100,241 -$268,924 -73% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $168,782 -$267,558 -61% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $236,519 -$257,198 -52% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $303,689 -$252,803 -45% 31 Dec 2021 10-K 10 Apr 2023 2022 FY
Q3 2021 $369,165 -$245,028 -40% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $436,340 -$236,461 -35% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $493,717 -$231,199 -32% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $556,492 -$241,421 -30% 31 Dec 2020 10-K 08 Apr 2022 2021 FY
Q3 2020 $614,193 -$28,212 -4.4% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $672,801 -$10,882 -1.6% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $724,916 +$777 +0.11% 31 Mar 2020 10-Q 29 Jun 2020 2020 Q1
Q4 2019 $797,913 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $642,405 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $683,683 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $724,139 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.